Thermo Fisher Scientific Inc.
New York Stock ExchangeTotal Valuation
Thermo Fisher Scientific Inc. carries a market capitalization of 174.52B, placing it among publicly traded companies globally. Its enterprise value stands at 224.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 174.52B |
| Enterprise Value | 224.85B |
Share Statistics
Thermo Fisher Scientific Inc. currently has 371.62M shares outstanding.
| Shares Outstanding | 371.62M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Thermo Fisher Scientific Inc. trades at a trailing price-to-earnings ratio of 26.99. The price-to-sales ratio is 4.09, and the price-to-book ratio stands at 3.03.
| PE Ratio | 26.99 |
| PS Ratio | 4.09 |
| PB Ratio | 3.03 |
| P/TBV Ratio | -8.30 |
| P/FCF Ratio | 18.83 |
| P/OCF Ratio | 22.30 |
Enterprise Valuation
On an enterprise value basis, Thermo Fisher Scientific Inc. trades at an EV/EBITDA multiple of 20.41 and an EV/FCF ratio of 20.09. The EV/Sales ratio of 4.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 27.40 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.97 |
| EV / EBITDA | 20.41 |
| EV / EBIT | 27.40 |
| EV / FCF | 20.09 |
Financial Position
Thermo Fisher Scientific Inc. maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 82.90, indicating elevated leverage, while an interest coverage ratio of 7.50 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.53 |
| Quick Ratio | 0.97 |
| Debt / Equity | 82.90 |
| Debt / EBITDA | 3.92 |
| Interest Coverage | 7.50 |
Financial Efficiency
Thermo Fisher Scientific Inc. posts a return on equity of 11.81 and a return on invested capital of 8.54.
| Return on Equity (ROE) | 11.81 |
| Return on Assets (ROA) | 6.45 |
| Return on Invested Capital (ROIC) | 8.54 |
| Return on Capital Employed (ROCE) | 8.47 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.99 |
Taxes
Over the trailing twelve months, Thermo Fisher Scientific Inc. has paid 522.00M in income taxes, reflecting an effective tax rate of 7.03.
| Income Tax | 522.00M |
| Effective Tax Rate | 7.03 |
Stock Price Statistics
Thermo Fisher Scientific Inc.'s stock has gained approximately 14.95606% over the past 52 weeks. The 50-day moving average sits at 480.15, while the 200-day moving average is 526.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | 14.95606% |
| 50-Day Moving Average | 480.15 |
| 200-Day Moving Average | 526.74 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Thermo Fisher Scientific Inc. generated 45.20B in revenue and converted that into 6.85B in net income, yielding earnings per share of 18.23. EBITDA reached 11.02B, while operating income came in at 8.21B.
| Revenue | 45.20B |
| Gross Profit | 18.43B |
| Operating Income | 8.21B |
| Pretax Income | 7.42B |
| Net Income | 6.85B |
| EBITDA | 11.02B |
| EBIT | 8.21B |
| Earnings Per Share (EPS) | 18.23 |
Balance Sheet
Thermo Fisher Scientific Inc. holds 3.26B in cash and equivalents against 43.16B in total debt, resulting in a net debt position of 39.91B. Total book value stands at 61.08B, with working capital of 7.70B providing operational flexibility.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 43.16B |
| Net Debt | 39.91B |
| Equity (Book Value) | 61.08B |
| Book Value Per Share | 162.44 |
| Working Capital | 7.70B |
Cash Flow
Thermo Fisher Scientific Inc. produced 8.29B in operating cash flow over the past twelve months. After subtracting -1.54B in capital expenditures, free cash flow totaled 6.75B - equivalent to 17.95 per share.
| Operating Cash Flow | 8.29B |
| Capital Expenditures | -1.54B |
| Free Cash Flow | 6.75B |
| FCF Per Share | 17.95 |
Margins
Thermo Fisher Scientific Inc. operates with a gross margin of 40.78, reflecting its pricing power and cost economics. The operating margin of 18.16 and net profit margin of 15.15 provide insight into operational efficiency.
| Gross Margin | 40.78 |
| Operating Margin | 18.16 |
| Pretax Margin | 16.42 |
| Profit Margin | 15.15 |
| EBITDA Margin | 24.38 |
Dividends & Yields
The company's payout ratio of 9.43 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.73 |
| Dividend Yield | N/A |
| Payout Ratio | 9.43 |
| Shareholder Yield | -1.62 |
| FCF Yield | 5.31 |
Stock Splits
Thermo Fisher Scientific Inc.'s most recent stock split took place on June 6, 1996 with a 2:3 split ratio.
| Last Split Date | 6/6/1996 |
| Split Ratio | 2:3 |
Scores
Thermo Fisher Scientific Inc. posts an Altman Z-Score of 6.08, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.08 |